Should pharma companies go further in the boycott of Russia?

Associate Professor Alex Polyakov

In response to Russia’s invasion of Ukraine and overwhelming destruction of property and loss of innocent lives, a number of western companies – from McDonalds to Apple – stopped or severely limited their activities in the Russian Federation.

One glaring exception appears to be the majority of western pharmaceutical companies that continue to supply medicines and equipment.

There is growing political and consumer pressure on these companies to take steps to join the concerted efforts designed to pressure the Russian government to stop the war in Ukraine.

The counterargument advanced by the companies revolves around the fact medicines are exempt from sanctions on humanitarian grounds.